P. P. Olimpieri

proABC-2: PRediction of AntiBody contacts v2 and its application to information-driven docking

F. Ambrosetti, T. H. Olsen, P. P. Olimpieri, 2020, bioRxiv.

Insights on protein thermal stability: a graph representation of molecular interactions

Pier Paolo Olimpieri, Rosalba Lepore, Lorenzo Di Rienzo, 2018 .

Mortality After Remdesivir Treatment of Pneumonia in Hospitalised Patients with Laboratory Confirmed COVID-19: National Data in the Italian Real-World Practice Collected by the AIFA Monitoring Register

P. P. Olimpieri, G. Palù, P. Russo, 2021 .

Mortality after Remdesivir Treatment of Pneumonia in Hospitalised Patients with Laboratory Confirmed COVID-19: National Data in the Italian Real-World Practice Collected by the AIFA Monitoring Register.

P. P. Olimpieri, P. Russo, S. Celant, 2021, SSRN Electronic Journal.

Chemosensory adaptations of the mountain fly Drosophila nigrosparsa (Insecta: Diptera) through genomics’ and structural biology’s lenses

P. P. Olimpieri, B. Schlick-Steiner, F. M. Steiner, 2017, Scientific Reports.

Antibody structural modeling with prediction of immunoglobulin structure (PIGS)

Anna Tramontano, Paolo Marcatili, Pier Paolo Olimpieri, 2014 .

An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis

P. P. Olimpieri, A. Foli, P. Milani, 2022, Leukemia.

Impact of the COVID‐19 pandemic on prescription of sacubitril/valsartan in Italy

P. P. Olimpieri, A. di Lenarda, G. Onder, 2022, European journal of heart failure.

Non-vitamin K antagonist oral anticoagulation agents in patients with atrial fibrillation: Insights from Italian monitoring registries

P. P. Olimpieri, A. di Lenarda, Furio Colivicchi, 2020, International journal of cardiology. Heart & vasculature.

Starting dose and dose adjustment of non-vitamin K antagonist oral anticoagulation agents in a nationwide cohort of patients with atrial fibrillation

P. P. Olimpieri, A. di Lenarda, A. Lenarda, 2020, Scientific Reports.